NM_153704.6(TMEM67):c.1321C>T (p.Arg441Cys) AND multiple conditions
- Germline classification:
- Pathogenic (1 submission)
- Last evaluated:
- Oct 31, 2018
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000763609.2
Allele description [Variation Report for NM_153704.6(TMEM67):c.1321C>T (p.Arg441Cys)]
NM_153704.6(TMEM67):c.1321C>T (p.Arg441Cys)
Condition(s)
- Name:
- COACH syndrome 1
- Identifiers:
- MONDO: MONDO:0800103; MedGen: C5435651; Orphanet: 1454; OMIM: 216360
- Name:
- Joubert syndrome 6 (JBTS6)
- Identifiers:
- MONDO: MONDO:0012539; MedGen: C1853153; Orphanet: 475; OMIM: 610688
- Name:
- Meckel syndrome, type 3 (MKS3)
- Synonyms:
- MECKEL-GRUBER SYNDROME, TYPE 3
- Identifiers:
- MONDO: MONDO:0011821; MedGen: C1846357; Orphanet: 564; OMIM: 607361
-
Babesia bigemina isolate Galed-943 RAP-1a (rap1a) gene, partial cds
Babesia bigemina isolate Galed-943 RAP-1a (rap1a) gene, partial cdsgi|910270134|gb|KP822951.1|Nucleotide
-
Babesia bigemina isolate Galed-9001 RAP-1a (rap1a) gene, partial cds
Babesia bigemina isolate Galed-9001 RAP-1a (rap1a) gene, partial cdsgi|910270138|gb|KP822953.1|Nucleotide
-
tripartite motif-containing protein 2 isoform 2 [Homo sapiens]
tripartite motif-containing protein 2 isoform 2 [Homo sapiens]gi|1770726473|ref|NP_001362443.1|Protein
-
tripartite motif-containing protein 2 isoform X4 [Homo sapiens]
tripartite motif-containing protein 2 isoform X4 [Homo sapiens]gi|2462596084|ref|XP_054205463.1|Protein
-
RecName: Full=Potassium voltage-gated channel subfamily S member 1; AltName: Ful...
RecName: Full=Potassium voltage-gated channel subfamily S member 1; AltName: Full=Delayed-rectifier K(+) channel alpha subunit 1; AltName: Full=Voltage-gated potassium channel subunit Kv9.1gi|24418458|sp|O88758.1|KCNS1_RATProtein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 8, 2024